Blood Products Market
Any component or portion of blood that is harvested from a donor for use in patients is referred to as a blood product. Not every patient requires complete blood transfusion; many simply require transfusion of certain blood components. Several blood components are isolated from the total blood in such circumstances. Platelets, red blood cells (RBCs), white blood cells (WBCs), fresh frozen plasma (FFP), clotting factors, and other blood products are among the blood products available. An individual is given a specific blood product depending on their condition. Blood is an extremely important bodily fluid that ensures the proper functioning of organs. However, there are a variety of chronic medical problems that cause the body’s red blood cell count to drop. Diseases like leukemia, cancer, and end-stage renal disease, for example, cause significant consequences that necessitate blood transfusions.
Blood Products Market: Key Players
Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis
American Red Cross
America`s Blood Centers
Mitsubishi Tanabe Pharma Corporation
Bharat Serums and Vaccines Ltd.
Bio Products Laboratory Ltd.
Bio-Rad Laboratories, Inc.
Canadian Blood Services
Rise in geriatric population
According to the World Health Organization, the worldwide population of people aged 60 and over will nearly double from 12 percent to 22 percent between 2015 and 2050, with 80 percent of the aging population residing in low- and middle-income nations. The world’s ageing population may result in a rise in illnesses that require plasma treatment. As a result, the market will develop faster as the senior population grows.
By Product Type
Fresh Frozen Plasma (FFP)
Red Blood Cells (RBCs)
White Blood Cells (WBCs)
Blood Products Market Dynamics
Blood Products Market Size
Supply & Demand
Competition & Companies Involved in the Market
Value Chain of the Market
Market Drivers and Restraints
Recent News Related to Market
North America is the market leader for blood plasma products, accounting for 44.2 percent of the market in 2018. This is owing to the increased prevalence of hemophilia and the FDA’s quick approval of plasma products.
In October 2018, The FDA revised its criteria on dried plasma products for blood transfusion, including everything from the best sources of input plasma to device submissions.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
COVID-19 pre and post business impact analysis
Detailed overview of the parent market
Changing market dynamics in the industry
In-depth market segmentation
What is the Blood Products Market growth?
Which segment accounted for the largest Blood Products Market share?
Who are the key players in the Blood Products Market?
Historical, current, and projected market size in terms of volume and value
Recent industry trends and developments
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint
Note: Although care has been taken to maintain the highest levels of accuracy in Our reports, recent market/vendor-specific changes may take time to reflect in the analysis.